Catalyst Biosciences, Inc.

Home » Catalyst Biosciences, Inc.

Secondary

Catalyst Biosciences, Inc.

Catalyst is a clinical-stage biopharmaceutical company developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia.

Symbol

CBIO

Last Closing Price
$35.60

Shares
2,200,000

Effective Date
February 13, 2018

Underwriters
Jones Trading, Ladenburg Thalmann

To view the prospectus for Catalyst Biosciences, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253